RARE

NASDAQ 已收盘

Ultragenyx Pharmaceutical

17.22 USD
▼-0.51-2.88%
盘后 17.06 -0.95%
2026-11-19
市值
$1.67B
市盈率
—
EPS
-5.18
股息率
—
52 周区间
12.73 – 39.89
成交量
3.12M
Beta
0.36
目标价
24.80
52W 低 12.7352W 高 39.89
价格走势

公司简介

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia; Mepsevii, an enzyme replacement therapy for the treatment...

关联新闻